In the long-term, chief executive officer Charl van Zyl wishes that using Rexulti to deal with frustration in Alzheimer’s individuals will certainly represent 40% of prescriptions in the United States.
发布者:BY MARKETWIRE,转转请注明出处:https://robotalks.cn/lundbeck-boss-sees-potential-to-double-alzheimers-prescriptions-on-rexulti/